Hepatobiliary ABC transporters: Physiology, regulation and implications for disease

Frontiers in Bioscience

Volumn 14, Issue 13, 2009, Pages 4904-4920

  Jonker, Johan W ^a   Stedman, Catherine A M ^b   Liddle, Christopher ^c   Downes, Michael ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ABC transporters; Bile acids; Cholesterol; Hepatocyte; Liver; Metabolism; Nuclear receptors; Review

Indexed keywords

ABC TRANSPORTER; BILE ACID; CELL RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; HEPATOBILIARY SYSTEM; HISTOLOGY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER; LIVER DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BILIARY TRACT; CHOLESTASIS, INTRAHEPATIC; HUMANS; LIVER; LIVER DISEASES; MODELS, BIOLOGICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 69149086685     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3576     Document Type: Article

References (150)

1. M. Trauner, and J. L. Boyer: Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83, 633-671(2003) (Pubitemid 36378680)
2. M. C. Carey, and J. T. Lamont: Cholesterol gallstone formation. 1. Physical-chemistry of bile and biliary lipid secretion. Prog Liver Dis 10, 139-163(1992)
3. P. J. Meier, and B. Stieger: Bile salt transporters. Annu Rev Physiol 64, 635-661(2002) (Pubitemid 34259244)
4. G. A. Kullak-Ublick, B. Stieger, and P. J. Meier: Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126, 322-342(2004) (Pubitemid 38040747)
5. R. L. Juliano, and V. Ling: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455, 152-162(1976)
6. C. F. Higgins: ABC transporter s: from microorganisms to man. Annu Rev Cell Biol 8, 67-113(1992)
7. M. Dean, Y. Hamon, and G. Chimini: The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42, 1007-1017(2001) (Pubitemid 32645780)
8. P. Borst, and R. Oude Elferink: Mammalian ABC transporters in health and disease. Annu Rev Biochem 71, 537-592(2002) (Pubitemid 34800230)
9. Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V., and Riordan, J. R.: The md r1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 141, 956-962(1986) (Pubitemid 17006141)
10. D. W. Shen, A. Fojo, J. E. Chin, I. B. Roninson, N. Richert, I. Pastan, and M. M. Gottesman: Human multidrugresistant cell lines: increased mdr1 expression can precede gene amplification. Science 232, 643-645(1986) (Pubitemid 16061975)
11. A. H. Schinkel, J. J. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. te Riele, A. J. Berns, and P. Borst: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502(1994) (Pubitemid 24153990)
12. K. L. Mealey, S. A. Bentjen, J. M. Gay, and G. H. Cantor: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11, 727-733(2001) (Pubitemid 33078243)
13. A. Sparreboom, J. van Asperen, U. Mayer, A. H. Schinkel, J. W. Smit, D. K. Meijer, P. Borst, W. J. Nooijen, J. H. Beijnen, and O. van Tellingen: Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94, 2031-2035(1997) (Pubitemid 27113956)
14. U. Mayer, E. Wagenaar, J. H. Beijnen, J. W. Smit, D. K. Meijer, J. van Asperen, P. Borst, and A. H. Schinkel: Substantial excretion of digoxin via the intes tinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a Pglycoprotein. Br J Pharmacol 119, 1038-1044(1996) (Pubitemid 26366502)
15. J. van Asperen, O. van Tellingen, and J. H. Beijnen: The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice. Drug Metab Dispos 28, 264-267(2000) (Pubitemid 30137049)
16. A. H. Schinkel, and J. W. Jonker: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55, 3-29(2003) (Pubitemid 36078452)
17. I. B. Roninson, J. E. Chin, K. G. Choi, P. Gros, D. E. Housman, A. Fojo, D. W. Shen, M. M. Gottesman, and I. Pastan: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcino ma cells. Proc Natl Acad Sci USA 83, 4538-4542(1986) (Pubitemid 16057084)
18. A. M. van der Bliek, F. Baas, T. ten Houte de Lange, P. M. Kooiman, T. van der Velde-Koerts, and P. Borst: The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J 6, 3325-3331(1987)
19. J. M. Croop, M. Raymond, D. Haber, A. Devault, R. J. Arceci, P. Gros, and D. E. Housman: The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9, 1346-1350(1989) (Pubitemid 19071705)
20. J. J. Smit, A. H. Schinkel, R. P. Oude Elferink, A. K. Groen, E. Wagenaar, L. van Deemter, C. A. Mol, R. Ottenhoff, N. M. van der Lugt, M. A. van Roon, et al.: Homozygous dis ruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462(1993) (Pubitemid 23335071)
21. J. M. de Vree, E. Jacquemin, E. Sturm, D. Cresteil, P. J. Bosma, J. Aten, J. F. Deleuze, M. Desrochers, M. Burdelski, O. Bernard, R. P. Oude Elferink, and M. Hadchouel: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95, 282-287(1998) (Pubitemid 28103945)
22. A. J. Smith, J. L. Timmermans-Hereijgers, B. Roelofsen, K. W. Wirtz, W. J. van Blitterswijk, J. J. Smit, A. H. Schinkel, and P. Borst: The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett 354, 263-266(1994) (Pubitemid 24344174)
23. S. Childs, R. L. Yeh, E. Georges, and V. Ling: Identification of a sister gene to P-glycoprotein. Cancer Res 55, 2029-2034(1995)
24. T. Gerloff, B. Stieger, B. Hagenbuch, J. Madon, L. Landmann, J. Roth, A. F. Hofmann, and P. J. Meier: The sister of Pglycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273, 10046-10050(1998) (Pubitemid 28183107)
25. T. Nishida, Z. Gatmaitan, M. Che, and I. M. Arias: Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc Natl Acad Sci USA 88, 6590-6594(1991) (Pubitemid 21914993)
26. S. S. Strautnieks, L. N. Bull, A. S. Knisely, S. A. Kocoshis, N. Dahl, H. Arnell, E. Sokal, K. Dahan, S. Childs, V. Ling, M. S. Tanner, A. F. Kagalwalla, A. Németh, J. Pawlowska, A. Baker, G. Mieli-Vergani, N. B. Freimer, R. M. Gardiner, and R. J. Thompson: A g ene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 20, 233-238(1998) (Pubitemid 28507666)
27. S. W. van Mil, W. L. van der Woerd, G. van der Brugge, E. Sturm, P. L. Jansen, L. N. Bull, I. E. van den Berg, R. Berger, R. H. Houwen, and L. W. Klomp: Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127, 379-384(2004) (Pubitemid 39091885)
28. C. Pauli-Magnus, T. Lang, Y. Meier, T. Zodan-Marin, D. Jung, C. Breymann, R. Zimmermann, S. Kenngott, U. Beuers, C. Reichel, R. Kerb, A. Penger, P. J. Meier, and G. A. Kullak-Ublick: Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 14, 91-102(2004) (Pubitemid 38253644)
29. L. Wang, C. J. Soroka, and J. L. Boyer: The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. J Clin Invest 110, 965-972(2002)
30. J. R. Plass, O. Mol, J. Heegsma, M. Geuken, J. de Bruin, G. Elling, M. Müller, K. N. Faber, and P. L. Jansen: A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump. J Hepatol 40, 24-30(2004) (Pubitemid 38064709)
31. P. Lam, C. L. Pearson, C. Soroka, S. Xu, A. Mennone, and J. L. Boyer: The Level of Plasma Membrane Expression in Progressive and Benign Mutations of the Bile Salt Export Pump (Bsep/Abcb11) Correlate with Severity of Cholestatic Diseases. Am J Physiol Cell Physiol 293, C1709-16 (2007) (Pubitemid 350085643)
32. R. Wang, M. Salem, I. M. Yousef, B. Tuchweber, P. Lam, S. J. Childs, C. D. Helgason, C. Ackerley, M. J. Phillips, and V. Ling: Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci USA 98, 2011-2016(2001) (Pubitemid 32165614)
33. R. Wang, P. Lam, L. Liu, D. Forrest, I. M. Yousef, D. Mignault, M. J. Phillips, and V. Ling: Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein. Hepatology 38, 1489-1499(2003) (Pubitemid 37466975)
34. P. Lam, R. Wang, and V. Ling: Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. Biochemistry 44, 12598-12605(2005) (Pubitemid 41324350)
35. V. Keitel, M. Burdelski, U. Warskulat, T. Kühlkamp, D. Keppler, D. Häussinger, and R. Kubitz: Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41, 1160-1172(2005) (Pubitemid 40593925)
36. G. Bouchard, H. M. Nelson, F. Lammert, L. B. Rowe, M. C. Carey, and B. Paigen: High-resolution maps of the murine Chromosome 2 region containing the cholesterol gallstone locus, Lith1. Mamm Genome 10, 1070-1074(1999) (Pubitemid 29513885)
37. D. Q. Wang, B. Paigen, and M. C. Carey: Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physicalchemistry of gallbladder bile. J Lipid Res 38, 1395-1411(1997) (Pubitemid 27332566)
38. F. Hoda, and R. M. Green: Hepatic canalicular membrane transport of bile salt in C57L/J and AKR/J mice: implications for cholesterol gallstone formation. J Membr Biol 196, 9-14(2003) (Pubitemid 37500810)
39. A. Henkel, Z. Wei, D. E. Cohen, and R. M. Green: Mice overexpressing hepatic Abcb11 rapidly develop cholesterol gallstones. Mamm Genome 16, 903-908(2005) (Pubitemid 41759832)
40. R. Mayer, J. Kartenbeck, M. Büchler, G. Jedlitschky, I. Leier, and D. Keppler: Expression of the MRP geneencoded conjugate export pump in liver and its selective absence from the canalicular membrane in transportdeficient mutant hepatocytes. J Cell Biol 131, 137-150(1995)
41. C. C. Paulusma, P. J. Bosma, G. J. Zaman, C. T. Bakker, M. Otter, G. L. Scheffer, R. J. Scheper, P. Borst, and R. P. Oude Elferink: Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271, 1126-1128(1996) (Pubitemid 26075228)
42. P. L. Jansen, W. H. Peters, and W. H. Lamers: Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 5, 573-579(1985) (Pubitemid 15029725)
43. S. Hosokawa, O. Tagaya, T. Mikami, Y. Nozaki, A. Kawaguchi, K. Yamatsu, and M. Shamoto: A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions. Lab Anim Sci 42, 27-34(1992)
44. K. Ito, H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama: Expression of the putative ATP-binding cassette region, homologous to that in multidrug resistance associated protein (MRP), is hereditarily defective in Eisai hyperbilirubinemic rats (EHBR). Int Hepatol Commun 292, 292-299(1996)
45. G. Jedlitschky, U. Hoffmann, and H. K. Kroemer: Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol 2, 351-366(2006) (Pubitemid 46141403)
46. A. T. Nies, and D. Keppler: The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 453, 643-659(2007) (Pubitemid 46192536)
47. C. G. Dietrich, D. R. de Waart, R. Ottenhoff, I. G. Schoots, and R. P. Elferink: Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in MRP2-deficient rats. Mol Pharmacol 59, 974-980(2001) (Pubitemid 32381575)
48. X. Y. Chu, J. R. Strauss, M. A. Mariano, J. Li, D. J. Newton, X. Cai, R. W. Wang, J. Yabut, D. P. Hartley, D. C. Evans, and R. Evers: Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). J Pharmaco. Exp Ther 317, 579-589(2006)
49. M. L. Vlaming, K. Mohrmann, E. Wagenaar, D. R. de Waart, R. P. Elferink, J. S. Lagas, O. van Tellingen, L. D. Vainchtein, H. Rosing, J. H. Beijnen, J. H. Schellens, and A. H. Schinkel: Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice. J Pharmacol Exp Ther 318, 319-327(2006)
50. K. Nezasa, X. Tian, M. K. Zamek-Gliszczynski, N. J. Patel, T. J. Raub, and K. L. Brouwer: Altered hepatobiliary disposition of 5 (and 6)-carboxy-2', 7'-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice. Drug Metab Dispos 34, 718-723(2006)
51. S. B. Patel, G. Salen, H. Hidaka, P. O. Kwiterovich, A. F. Stalenhoef, T. A. Miettinen, S. M. Grundy, M. H. Lee, J. S. Rubenstein, M. H. Polymeropoulos, and M. J. Brownstein: Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest 102, 1041-1044(1998) (Pubitemid 28419249)
52. K. E. Berge, H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H. H. Hobbs: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771-1775(2000) (Pubitemid 32004809)
53. M. H. Lee, K. Lu, S. Hazard, H. Yu, S. Shulenin, H. Hidaka, H. Kojima, R. Allikmets, N. Sakuma, R. Pegoraro, A. K. Srivastava, G. Salen, M. Dean, and S. B. Patel: Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27, 79-83(2001) (Pubitemid 32044523)
54. A. K. Bhattacharyya, and W. E. Connor: Betasitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 53, 1033-1043(1974)
55. L. Yu, R. E. Hammer, J. Li-Hawkins, K. Von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs: Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99, 16237-16242(2002) (Pubitemid 35462779)
56. C. Yang, L. Yu, W. Li, F. Xu, J. C. Cohen, and H. H. Hobbs: Disruption of cholesterol homeostasis by plant sterols. J Clin Invest 114, 813-822(2004) (Pubitemid 39578740)
57. L. Yu, J. Li-Hawkins, R. E. Hammer, K. E. Berge, J. D. Horton, J. C. Cohen, and H. H. Hobbs: Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110, 671-680(2002) (Pubitemid 34988791)
58. L. Yu, J. York, K. von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs: Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 278, 15565-15570(2003) (Pubitemid 36799664)
59. H. Wittenburg, M. A. Lyons, R. Li, G. A. Churchill, M. C. Carey, and B. Paigen: FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 125, 868-881(2003) (Pubitemid 37070703)
60. H. Wittenburg, M. A. Lyons, R. Li, U. Kurtz, J. Mössner, G. A. Churchill, M. C. Carey, and B. Paigen: Association of a lithogenic Abcg5/Abcg8 allele on Chromosome 17 (Lith9) with cholesterol gallstone formation in PERA/EiJ mice. Mamm Genome 16, 495-504(2005) (Pubitemid 41278426)
61. S. Buch, C. Schafmayer, H. Völzke, C. Becker, A. Franke, H. von Eller-Eberstein, C. Kluck, I. Bässmann, M. Brosch, F. Lammert, J. F. Miquel, F. Nervi, M. Wittig, D. Rosskopf, B. Timm, C. Höll, M. Seeger, A. ElSharawy, T. Lu, J. Egberts, F. Fändrich, U. R. Fölsch, M. Krawczak, S. Schreiber, P. Nürnberg, J. Tepel, and J. Hampe: A genomewide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 39, 995-999(2007) (Pubitemid 47185186)
62. F. Grünhage, M. Acalovschi, S. Tirziu, M. Walier, T. F. Wienker, A. Ciocan, O. Mosteanu, T. Sauerbruch, and F. Lammert: Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 46, 793-801(2007) (Pubitemid 47436126)
63. J. A. Hubacek, K. E. Berge, J. C. Cohen, and H. H. Hobbs: Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia. Hum Mutat 18, 359-360(2001)
64. K. E. Berge, K. von Bergmann, D. Lutjohann, R. Guerra, S. M. Grundy, H. H. Hobbs, and J. C. Cohen: Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 43, 486-494(2002) (Pubitemid 34252279)
65. L. A. Doyle, W. Yang, L. V. Abruzzo, T. Krogmann, Y. Gao, A. K. Rishi, and D. D. Ross: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95, 15665-15670(1998) (Pubitemid 29018757)
66. J. S. Lee, S. Scala, Y. Matsumoto, B. Dickstein, R. Robey, Z. Zhan, G. Altenberg, and S. E. Bates: Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J Cell Biochem 65, 513-526(1997) (Pubitemid 27240917)
67. R. W. Robey, O. Polgar, J. Deeken, K. W. To, and S. E. Bates: ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26, 39-57(2007) (Pubitemid 46452182)
68. M. Maliepaard, G. L. Scheffer, I. F. Faneyte, M. A. van Gastelen, A. C. Pijnenborg, A. H. Schinkel, M. J. van de Vijver, R. J. Scheper, and J. H. Schellens: Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61, 3458-3464(2001) (Pubitemid 32695041)
69. J. W. Jonker, G. Merino, S. Musters, A. E. van Herwaarden, E. Bolscher, E. Wagenaar, E. Mesman, T. C. Dale, and A. H. Schinkel: The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 11, 127-129(2005) (Pubitemid 40321346)
70. A. E. van Herwaarden, E. Wagenaar, G. Merino, J. W. Jonker, H. Rosing, J. H. Beijnen, and A. H. Schinkel: Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol 27, 1247-1253(2007) (Pubitemid 46239808)
71. J. W. Jonker, J. W. Smit, R. F. Brinkhuis, M. Maliepaard, J. H. Beijnen, J. H. Schellens, and A. H. Schinkel: Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92, 1651-1656(2000)
72. A. E. van Herwaarden, J. W. Jonker, E. Wagenaar, R. F. Brinkhuis, J. H. Schellens, J. H. Beijnen, and A. H. Schinkel: The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Cancer Res 63, 6447-6452(2003) (Pubitemid 37255195)
73. S. Zhou, J. D. Schuetz, K. D. Bunting, A. M. Colapietro, J. Sampath, J. J. Morris, I. Lagutina, G. C. Grosveld, M. Osawa, H. Nakauchi, and B. P. Sorrentino: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype. Nat Med 7, 1028-1034(2001) (Pubitemid 32937383)
74. C. W. Scharenberg, M. A. Harkey, and B. Torok-Storb: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99, 507-512(2002) (Pubitemid 34533085)
75. J. W. Jonker, M. Buitelaar, E. Wagenaar, M. A. van der Valk, G. L. Scheffer, R. J. Scheper, T. Plösch, F. Kuipers, R. P. Elferink, H. Rosing, J. H. Beijnen, and A. H. Schinkel: The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 99, 15649-15654(2002) (Pubitemid 35403986)
76. S. Zhou, J. J. Morris, Y. Barnes, L. Lan, J. D. Schuetz, and B. P. Sorrentino: Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 99, 12339-12344(2002)
77. T. M. Cox, G. J. Alexander, and R. P. Sarkany, R. P: Protoporphyria. Semin Liver Dis 18, 85-93(1998) (Pubitemid 28133447)
78. J. R. Bloomer, M. J. Phillips, D. L. Davidson, and G. Klatskin: Hepatic disease in erythropoietic protoporphyria. Am J Med 58, 869-882(1975)
79. J. W. Jonker, S. Musters, M. L. Vlaming, T. Plösch, K. E. Gooijert, M. J. Hillebrand, H. Rosing, J. H. Beijnen, H. J. Verkade, and A. H. Schinkel: Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. Am J Physiol Cell Physiol 292, C2204-2212 (2007) (Pubitemid 47080514)
80. D. J. Mangelsdorf, and R. M. Evans: The RXR heterodimers and orphan receptors. Cell 83, 841-850(1995) (Pubitemid 26006526)
81. A. L. Bookout, Y. Jeong, M. Downes, R. T. Yu, R. M. Evans, and D. J. Mangelsdorf: Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789-799(2006) (Pubitemid 44233630)
82. X. Yang, M. Downes, R. T. Yu, A. L. Bookout, W. He, M. Straume, D. J. Mangelsdorf, and R. M. Evans: Nuclear receptor expression links the circadian clock to metabolism. Cell 126, 801-810(2006) (Pubitemid 44233631)
83. J. George, and C. Liddle: Nonalcoholic Fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. Mol Pharm 5, 49-59(2008) (Pubitemid 351300034)
84. W., Seol, H. S. Choi, and D. D. Moore: Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 9, 72-85(1995)
85. B. M. Forman, E. Goode, J. Chen, A. E. Oro, D. J. Bradley, T. Perlmann, D. J. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, R. M. Evans, and C. Weinberger: Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693(1995)
86. M. Makishima, A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan: Identification of a nuclear receptor for bile acids. Science 284, 1362-1365(1999) (Pubitemid 29289663)
87. D. J. Parks, S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, and J. M. Lehmann: Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368(1999) (Pubitemid 29289664)
88. J. Yu, J. L. Lo, L. Huang, A. Zhao, E. Metzger, A. Adams, P. T. Meinke, S. D. Wright, and J. Cui: Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 277, 31441-31447(2002) (Pubitemid 34968944)
89. P. R. Maloney, D. J. Parks, C. D. Haffner, A. M. Fivush, G. Chandra, K. D. Plunket, K. L. Creech, L. B. Moore, J. G. Wilson, M. C. Lewis, S. A. Jones, and T. M. Willson: Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 43, 2971-2974(2000) (Pubitemid 30626755)
90. M. Downes, M. A. Verdecia, A. J. Roecker, R. Hughes, J. B. Hogenesch, H. R. Kast-Woelbern, M. E. Bowman, J. L. Ferrer, A. M. Anisfeld, P. A. Edwards, J. M. Rosenfeld, J. G. Alvarez, J. P. Noel, K. C. Nicolaou, and R. M. Evans: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 11, 1079-1092(2003) (Pubitemid 36566328)
91. M. Ananthanarayanan, N. Balasubramanian, M. Makishima, D. J. Mangelsdorf, and F. J. Suchy: Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276, 28857-28865(2001)
92. T. Gerloff, A. Geier, I. Roots, P. J. Meier, and C. Gartung: Functional analysis of the rat bile salt export pump gene promoter. Eur J Biochem 269, 3495-3503(2002)
93. J. R. Plass, O. Mol, J. Heegsma, M. Geuken, K. N. Faber, P. L. Jansen, and M. Müller: Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35, 589-596(2002) (Pubitemid 34183962)
94. E. G. Schuetz, S. Strom, K. Yasuda, V. Lecureur, M. Assem, C. Brimer, J. Lamba, R. B. Kim, V. Ramachandran, B. J. Komoroski, R. Venkataramanan, H. Cai, C. J. Sinal, F. J. Gonzalez, and J. D. Schuetz: Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276, 39411-39418(2001) (Pubitemid 37371319)
95. X. Song, R. Kaimal, B. Yan, and R. Deng: Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression. J Lipid Res 49, 973-984(2008)
96. B. Goodwin, S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, P. R. Maloney, T. M. Willson, and S. A. Kliewer: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6, 517-526(2000)
97. T. T. Lu, M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, and D. J. Mangelsdorf: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6, 507-515(2000)
98. Y. K. Lee, H. Dell, D. H. Dowhan, M. Hadzopoulou-Cladaras, and D. D. Moore: The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol 20, 187-195(2000) (Pubitemid 30002560)
99. Y. K. Lee, and D. D. Moore: Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner. J Biol Chem 277, 2463-2467(2002) (Pubitemid 34953268)
100. C. Handschin, and U. A. Meyer: Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 433, 387-396(2005) (Pubitemid 39592793)
101. J. M. Lehmann, S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. M. Willson: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272, 3137-3140(1997) (Pubitemid 27066798)
102. B. Goodwin, M. A. Watson, H. Kim, J. Miao, J. K. Kemper, and S. A. Kliewer: Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol 17, 386-394(2003) (Pubitemid 36315633)
103. A. del Castillo-Olivares, and G. Gil: Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alphahydroxylase transcription. Nucleic Acids Res 28, 3587-3593(2000)
104. A. del Castillo-Olivares, J. A. Campos, W. M. Pandak, and G. Gil: Role of FTF/LRH-1 on bile acid biosynthesis. A known nuclear receptor activator that can Act as a suppressor of bile acid biosynthesis. J Biol Chem 279, 16813-16821(2004) (Pubitemid 38509384)
105. D. J. Shin, J. A. Campos, G. Gil, and T. F. Osborne: PGC-1alpha activates CYP7A1 and bile acid biosynthesis. J Biol Chem 278, 50047-50052(2003) (Pubitemid 37548841)
106. L. Wang, Y. K. Lee, D. Bundman, Y. Han, S. Thevananther, C. S. Kim, S. S. Chua, P. Wei, R. A. Heyman, M. Karin, and D. D. Moore: Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2, 721-731(2002) (Pubitemid 34650069)
107. S. Bhalla, C. Ozalp, S. Fang, L. Xiang, and J. K. Kemper: Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem 279, 45139-45147(2004) (Pubitemid 39430929)
108. J. A. Holt, G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, D. Y. Wang, T. A. Mansfield, S. A. Kliewer, B. Goodwin, and S. A. Jones: Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17, 1581-1591(2003) (Pubitemid 36828786)
109. H. Akita, H. Suzuki, K. Ito, S. Kinoshita, N. Sato, H. and Y. Sugiyama: Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 1511, 7-16(2001) (Pubitemid 32206667)
110. H. R. Kast, B. Goodwin, P. T. Tarr, S. A. Jones, A. M. Anisfeld, C. M. Stoltz, P. Tontonoz, S. Kliewer, T. M. Willson, and P. A. Edwards: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277, 2908-2915(2002) (Pubitemid 34953324)
111. M. Wagner, P. Fickert, G. Zollner, A. Fuchsbichler, D. Silbert, O. Tsybrovskyy, K. Zatloukal, G. L. Guo, J. D. Schuetz, F. J. Gonzalez, H. U. Marschall, H. Denk, and M. Trauner: Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125, 825-838(2003) (Pubitemid 37070700)
112. S. Teng, and M. Piquette-Miller: The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312, 841-848(2005) (Pubitemid 40189587)
113. S. Teng, and M. Piquette-Miller: Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 151, 367-376(2007) (Pubitemid 46842676)
114. G. Zollner, P. Fickert, D. Silbert, A. Fuchsbichler, H. U. Marschall, K. Zatloukal, H. Denk, and M. Trauner: Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38, 717-727(2003) (Pubitemid 36613336)
115. L. Huang, A. Zhao, J. L. Lew, T. Zhang, Y. Hrywna, J. R. Thompson, N. de Pedro, I. Royo, R. A. Blevins, F. Peláez, S. D. Wright, and J. Cui: Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 278, 51085-51090(2003) (Pubitemid 38020343)
116. Y. Liu, J. Binz, M. J. Numerick, S. Dennis, G. Luo, B. Desai, K. I. MacKenzie, T. A. Mansfield, S. A. Kliewer, B. Goodwin, and S. A. Jones: Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra-and extrahepatic cholestasis. J Clin Invest 112, 1678-1687(2003) (Pubitemid 38063725)
117. C. J. Sinal, M. Tohkin, M. Miyata, J. M. Ward, G. Lambert, and F. J. Gonzalez: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731-744(2000)
118. T. Kok, V. W. Bloks, H. Wolters, R. Havinga, P. L. Jansen, B. Staels, and F. Kuipers: Peroxisome proliferatoractivated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 369, 539-547(2003) (Pubitemid 36246237)
119. J. J. Repa, K. E. Berge, C. Pomajzl, J. A. Richardson, H. Hobbs, and D. J. Mangelsdorf: Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277, 18793-800(2002) (Pubitemid 34952438)
120. L. A. Freeman, A. Kennedy, J. Wu, S. Bark, A. T. Remaley, S. Santamarina-Fojo, and H. B. Brewer Jr: The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. J Lipid Res 45:1197-1206(2004) (Pubitemid 38802623)
121. K. W. Scotto: Transcriptional regulation of ABC drug transporters. Oncogene 22, 7496-7511(2003) (Pubitemid 37487172)
122. J. Sun, Z. G. He, G. Cheng, S. J. Wang, X. H. Hao, and M. J. Zhou: Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit 10, RA5-14 (2004) (Pubitemid 38176014)
123. T. W. Synold, I. Dussault, and B. M. Forman: The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7, 584-590(2001) (Pubitemid 32448326)
124. J. M. Maglich, C. M. Stoltz, B. Goodwin, D. Hawkins-Brown, J. T. Moore, and S. A. Kliewer: Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62, 638-646(2002) (Pubitemid 36329382)
125. G. L. Guo, G. Lambert, M. Negishi, J. M. Ward, H. B. Brewer Jr, S. A. Kliewer, F. J. Gonzalez, and C. J. Sinal: Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity. J Biol Chem 278, 45062-45071(2003) (Pubitemid 37432638)
126. T. Mitin, L. L. Von Moltke, M. H. Court, and D. J. Greenblatt: Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor. Drug Metab Dispos 32, 779-782(2004) (Pubitemid 38955604)
127. C. Stedman, C. Liddle, S. Coulter, J. Sonoda, J. G. Alvarez, R. M. Evans, and M. Downes: Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci USA 103, 11323-11328(2006) (Pubitemid 44156516)
128. P. L. Ee, S. Kamalakaran, D. Tonetti, X. He, D. D. Ross, and W. T. Beck: Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene. Cancer Res 64, 1247-1251(2004) (Pubitemid 38235590)
129. I. Szatmari, G. Vámosi, P. Brazda, B. L. Balint, S. Benko, L. Széles, V. Jeney, C. Ozvegy-Laczka, A. Szántó, E. Barta, J. Balla, B. Sarkadi, and L. Nagy: Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem 281, 23812-23823(2006) (Pubitemid 44274157)
130. S. Chitturi, and G. C. Farrell: Drug-induced cholestasis. Semin Gastrointest Dis 12, 113-124(2001) (Pubitemid 32436122)
131. M. Trauner, and J. L. Boyer: Cholestatic syndromes. Curr Opin Gastroenterol 20, 220-230(2004) (Pubitemid 38526772)
132. A. F. Hofmann: Cholestatic liver disease: pathophysiology and therapeutic options. Liver 22, 14-19(2002)
133. H. Higuchi, H. Miyoshi, S. F. Bronk, H. Zhang, N. Dean, and G. J. Gores: Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. J Pharmacol Exp Ther 299, 866-873(2001) (Pubitemid 33104953)
134. R. E. Poupon: Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past - issues for the future. J Hepatol 32, 685-688(2000) (Pubitemid 30180390)
135. C. Corpechot, F. Carrat, A. Bahr, Y. Chretien, and R. E. Poupon: The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128, 297-303(2005) (Pubitemid 40431083)
136. B. A. Mullally, and W. F. Hansen: Intrahepatic cholestasis of pregnancy: review of the literature. Obstet Gynecol Surv 57, 47-52(2002) (Pubitemid 34027940)
137. M. Leuschner, C. F. Dietrich, T. You, C. Seidl, J. Raedle, G. Herrmann, H. Ackermann, and U. Leuschner: Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut 46, 121-126(2000) (Pubitemid 30307689)
138. M. G. Donner, and D. Keppler: Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34, 351-359(2001) (Pubitemid 32702348)
139. G. Zollner, P. Fickert, R. Zenz, A. Fuchsbichler, C. Stumptner, L. Kenner, P. Ferenci, R. E. Stauber, G. J. Krejs, H. Denk, K. Zatloukal, and M. Trauner: Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33, 633-646(2001) (Pubitemid 32185226)
140. J. L. Staudinger, B. Goodwin, S. A. Jones, D. Hawkins-Brown, K. I. MacKenzie, A. LaTour, Y. Liu, C. D. Klaassen, K. K. Brown, J. Reinhard, T. M. Willson, B. H. Koller, and S. A. Kliewer: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98, 3369-3374(2001) (Pubitemid 32220852)
141. W. Xie, A. Radominska-Pandya, Y. Shi, C. M. Simon, M. C. Nelson, E. S. Ong, D. J. Waxman, and R. M. Evans: An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98, 3375-3380(2001) (Pubitemid 32220853)
142. C. A. Stedman, C. Liddle, S. A. Coulter, J. Sonoda, J. G. Alvarez, D. D. Moore, R. M. Evans, and M. Downes: Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci USA 102, 2063-2068(2005) (Pubitemid 40262012)
143. G. Zollner, P. Fickert, A. Fuchsbichler, D. Silbert, M. Wagner, S. Arbeiter, F. J. Gonzalez, H. U. Marschall, K. Zatloukal, H. Denk, and M. Trauner: Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol 39, 480-488(2003) (Pubitemid 37204645)
144. H. U. Marschall, M. Wagner, K. Bodin, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, A. Fuchsbichler, J. Sjovall, and M. Trauner: Fxr (-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 47, 582-592(2006). (Pubitemid 43345599)
145. A. F. Hofmann: Primary and secondary prevention of gallstone disease: implications for patient management and research priorities. Am J Surg 165:541-548(1993) (Pubitemid 23276846)
146. H. Uppal, Y. Zhai, A. Gangopadhyay, S. Khadem, S. Ren, J. A. Moser, and W. Xie: Activation of liver X receptor sensitises mice to gallbladder cholesterol crystallization. Hepatology 47, 1331-1342(2008) (Pubitemid 351547919)
147. M. Downes, and C. Liddle: Look Who's Talking: Nuclear Receptors in the Liver and Gastrointestinal Tract. Cell Metab 7, 195-199(2008) (Pubitemid 351285533)
148. L. W. Chinn, and D. L. Kroetz: ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther 81, 265-269(2007) (Pubitemid 46174824)
149. G. Abboud, and N. Kaplowitz: Drug-induced liver injury. Drug Saf 30, 277-294(2007) (Pubitemid 46624528)
150. S. L. Friedman: Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88, 125-172(2008)